Ipamorelin Research Peptide Specifications
| Product |
Ipamorelin |
| Unit Size |
5mg or 10mg per vial |
| Unit Quantity |
1 vial |
| Sequence |
Aib-His-D-2-Nal-D-Phe-Lys-NH2 |
| Molecular Formula |
C38H49N9O5 |
| Molecular Weight |
Approximately 711.9 g/mol |
| CAS Number |
170851-70-4 |
| Form |
Lyophilized white powder |
| Source |
Chemical synthesis |
| Purity |
Greater than 99% by HPLC |
| Analytical Testing |
Third-party identity and purity testing; review the batch-specific COA for applicable methods and results |
| Storage |
Store the lyophilized material at -20 °C in a dry, dark environment unless the batch documentation specifies otherwise |
| Intended Use |
Controlled laboratory research and analytical evaluation only |
Research Context
Ipamorelin has been described in published preclinical literature as a selective growth hormone secretagogue receptor ligand. Its defined sequence and reported receptor selectivity make it relevant to controlled studies involving:
- GHS-R binding and ligand-recognition assays
- Receptor selectivity and comparative agonist characterization
- Structure-activity relationship research
- Secretagogue receptor signaling in validated in vitro systems
- Analytical method development and reference-standard comparison
These descriptions identify areas of laboratory investigation only. They do not establish clinical utility, safety, efficacy, or suitability for use in humans or animals.
Independent Testing and Batch Documentation
Nordsci Peptides uses independent analytical testing to evaluate product identity and purity before release. Researchers should consult the Certificate of Analysis associated with the product lot they receive rather than relying on a general specification alone.
Batch documentation may include:
- Product and lot identification
- Analytical method information
- Purity results
- Identity data, when applicable
- Testing laboratory information
- Test and release dates
The COA should be reviewed alongside the product label and the laboratory's internal receiving and material-control procedures.
Laboratory Storage and Handling
Keep the vial sealed and away from heat, moisture, and direct light. Store at -20 °C in a dry, dark environment unless different conditions appear on the product label or batch-specific documentation. Laboratories are responsible for establishing validated handling, stability, storage, and disposal procedures appropriate to their equipment, methods, and regulatory requirements.
This page does not provide preparation, dosing, administration, or application instructions.
Research Procurement Considerations
Before adding Ipamorelin to a laboratory workflow, confirm that the product specifications and supporting documentation align with the planned analytical method or approved research protocol. Relevant review criteria may include:
- Batch-specific identity and purity documentation
- Labeled content and lot traceability
- Sequence, molecular formula, and molecular weight
- Storage requirements
- Internal receipt, inventory, handling, and disposal controls
- Institutional and jurisdictional requirements applicable to the research
Use Restrictions
Ipamorelin supplied by Nordsci Peptides is intended exclusively for laboratory research, analytical evaluation, and controlled scientific experimentation.
Not for human use. Not for veterinary use. Not for human or animal consumption. Not for diagnostic, therapeutic, food, drug, cosmetic, compounding, or dietary-supplement use. Not intended to diagnose, treat, cure, or prevent any disease or condition.
Scientific References
- Raun K, Hansen BS, Johansen NL, et al. Ipamorelin, the first selective growth hormone secretagogue. European Journal of Endocrinology. 1998;139(5):552-561. doi:10.1530/eje.0.1390552.
- National Center for Biotechnology Information. PubChem Compound Summary: Ipamorelin.
All product information is provided for laboratory and educational reference only.